Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Mesa Biotech Inc.

Mesa Biotech has developed and commercialized a PCR-based rapid point-of-care testing platform available for detecting infectious diseases including SARS-CoV-2, Influenza A and B, respiratory syncytial virus (RSV) and Strep A. Mesa Biotech's patented technology expands the availability of gold standard nucleic acid PCR amplification to point-of-care diagnostics. The company is based in San Diego, California and has approximately 500 employees and revenues in 2020 of approximately $45 million. Mesa Biotech's Accula™ Flu A/Flu B, RSV and Strep A tests have obtained 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA) waivers from the U.S. Food and Drug Administration (FDA). Additionally, the Accula System has received Emergency Use Authorization (EUA) from the FDA for SARS-CoV-2 in vitro diagnostic testing and is now available for use in patient care settings, providing results within 30 minutes, with higher accuracy than other rapid tests on the market. *


Period Start 2021-01-19 existent
  Group Thermo Fisher (Group)
Products Industry molecular diagnostics
  Industry 2 PCR test (clinical diagnostics)
Person Person Chakravarty, Ingo (Mesa Biotech 202101 CEO)
Region Region San Diego, CA
  Country United States (USA)
  City n. a. San Diego, CA
    Address record changed: 2021-01-19
Basic data Employees D: 101 to 500 (2021-01-19)
  Currency USD
  Annual sales 45,000,000 (sales, annual (2020) 2020-12-31)
    * Document for �About Section�: Thermo Fisher Scientific Inc.. (1/19/21). "Press Release: Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech". Waltham, MA.
Record changed: 2021-01-19


Picture [iito] [LSE] Business Portal 650x200px

More documents for Thermo Fisher (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Berlin Partner Health Capital Computational Biology 2022 650x300px

» top